Tenet Healthcare (Tenet Healthcare (THC)) had a Friday to remember. The hospital operator reported second-quarter results that blew past Wall Street estimates, and then did something even better: it raised its full-year outlook by a wide margin. Investors responded by sending the stock up more than 16%.
The numbers tell the story. Tenet posted adjusted earnings of $6.12 per share for the quarter, crushing the analyst consensus of $4.23. Revenue came in at $5.63 billion, up 6.8% from a year ago and ahead of the $5.43 billion analysts were looking for. That's the kind of beat that gets attention.
Same-Store Growth and Cost Control
CEO Saum Sutaria credited the strong quarter to solid same-store revenue growth and disciplined expense management. "Strong same-store revenue growth and effective expense management drove our fundamental outperformance in the second quarter of 2026 compared to our original assumptions," he said.
During the earnings call, Sutaria acknowledged that there's still uncertainty around payer mix and insurance enrollment in the Exchanges and Medicaid. But he said the company's growth initiatives and cost controls helped offset those headwinds. In other words, Tenet is managing what it can control, and it's paying off.
Higher-Acuity Procedures Boost Hospital Performance
Tenet's ambulatory care segment posted revenue of $1.39 billion, up 9.3% from a year earlier. Growth was driven by higher same-facility net patient service revenue, facility acquisitions, and expanded service lines. Same-facility ambulatory net patient service revenue increased 5.0%. While cases declined 1.2%, net revenue per case rose 6.3% because of higher-acuity procedures and a more favorable service mix. So, fewer cases but more revenue per case — a good trade-off.
The hospital segment also performed well, with revenue up 6.0% to $4.24 billion, supported by higher adjusted admissions and increased patient acuity. Lower Exchange admissions created an unfavorable payer mix that partially offset the gains, but the overall trend was positive. Same-hospital net patient service revenue per adjusted admission rose 3.3% year over year, reflecting stronger commercial employer revenue and higher Medicaid supplemental payments.
2026 Outlook Gets a Major Upgrade
Here's where things get really interesting. Tenet raised its fiscal 2026 adjusted earnings guidance to a range of $20.30 to $21.69 per share, up from its prior outlook of $16.38 to $18.68 per share. That new range is well above the analyst consensus estimate of $17.88 per share. The company also lifted its full-year revenue guidance to $21.9 billion-$22.5 billion from $21.5 billion-$22.3 billion. Analysts had expected revenue of about $22.0 billion, so the new range brackets that nicely.
But that's not all. Tenet also increased its expectations for acquisitions. Sutaria said the company now expects to spend more than $300 million on mergers and acquisitions in 2026, citing completed ambulatory surgery acquisitions and a strong deal pipeline. That's a signal that Tenet sees opportunities to grow through deals, not just organic performance.
As of Friday's close, Tenet shares were up 16.52% at $231.90. For a company that just raised its outlook by such a wide margin, the market's enthusiasm makes sense.
